Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.
Article
CAS
Google Scholar
Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.
Article
Google Scholar
Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34:1249–57.
Article
Google Scholar
Liu X, Li C, Gong H, Cui Z, Fan L, Yu W, et al. An economic evaluation for prevention of diabetes mellitus in a developing country: a modelling study. BMC Public Health. 2013;13:729.
Article
Google Scholar
Khunti K, Gray LJ, Skinner T, Carey ME, Realf K, Dallosso H, et al. Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. BMJ. 2012;344:e2333.
Article
Google Scholar
Azharuddin M, Adil M, Sharma M, Gyawali B. A systematic review and meta-analysis of non-adherence to anti-diabetic medication: evidence from low- and middle-income countries. Int J Clin Pract. 2021;75:e14717.
Article
Google Scholar
Leite RGOF, Banzato LR, Galendi JSC, Mendes AL, Bolfi F, Veroniki AA, et al. Effectiveness of non-pharmacological strategies in the management of type 2 diabetes in primary care: a protocol for a systematic review and network meta-analysis. BMJ Open. 2020;10:e034481.
Article
Google Scholar
Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: a systematic review and meta-analysis. Res Social Administrative Pharm. 2019;15:1057–67.
Article
Google Scholar
You LX, Selvadurai S, Yee CK, Noh NB, Chin G, Joyce T, et al. Impact of pharmacist-managed diabetes medication therapy adherence clinic (DMTAC) in government health clinics. Malays J Pharm Sci. 2015;13:43–51.
Google Scholar
Lim PC, Lim K, Embee ZC, Hassali MA, Thiagarajan A, Khan TM. Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia. Pak J Pharm Sci. 2016;29(2):595–601.
Google Scholar
Lau BT, Ismail SZ, Ng SY, Mohmmad N. Impact of pharmacist-led diabetes program on glycated hemoglobin and diabetes-related hospitalizations in a district-level hospital: a pilot retrospective cohort study. Int J Adv Life Sci Res. 2018;1:26–36.
Google Scholar
Milosavljevic A, Aspden T, Harrison J. Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review. Int J Pharm Pract. 2018;26:387–97.
Article
Google Scholar
Van Eikenhorst L, Taxis K, van Dijk L, de Gier H. Pharmacist-led self-management interventions to improve diabetes outcomes. A systematic literature review and meta-analysis. Front Pharmacol. 2017;8:891.
Newman TV, San-Juan-Rodriguez A, Parekh N, Swart ECS, Klein-Fedyshin M, Shrank WH, et al. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: an umbrella review. Res Social Administrative Pharm. 2020;16:1155–65.
Article
Google Scholar
Peters M, Godfrey C, Mcinerney P, Soares C, Khalil H, Parker D. Methodology for JBI scoping reviews. Joanna Briggs Institute; 2015.
Mahwi TO, Kawa AO. Role of the Pharmaceutical Care in the management of patients with type 2 diabetes Mellitus. Int J Pharm Sci Res. 2013;14:1363–9.
Google Scholar
Clifford RM, Batty KT, Davis TME, Davis W, Stein G, Stewart G, et al. A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. Int J Pharm Pract. 2002;10:85–9.
Article
Google Scholar
Phumipamorn S, Pongwecharak J, Soorapan S, Pattharachayakul S. Effects of the pharmacist’s input on glycaemic control and cardiovascular risks in muslim diabetes. Prim Care Diabetes. 2008;2:31–7.
Article
Google Scholar
Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon J-P, et al. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial: effectiveness of a pharmacist intervention in diabetes care. J Clin Pharm Ther. 2011;36:602–13.
Article
CAS
Google Scholar
Jacobs M, Sherry PS, Taylor LM, Amato M, Tataronis GR, Cushing G. Pharmacist assisted Medication Program enhancing the regulation of diabetes (PAMPERED) study. J Am Pharmacists Association. 2012;52:613–21.
Article
Google Scholar
Shah M, Norwood CA, Farias S, Ibrahim S, Chong PH, Fogelfeld L. Diabetes Transitional Care from Inpatient to Outpatient setting: Pharmacist Discharge Counseling. J Pharm Pract. 2013;26:120–4.
Article
Google Scholar
Butt M, Mhd Ali A, Bakry MM, Mustafa N. Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life: a randomised controlled study. Saudi Pharm J. 2016;24:40–8.
Article
Google Scholar
Samtia A, Rasool M, Ranjha N, Usman F, Javed I. A multifactorial intervention to Enhance Adherence to Medications and Disease-Related knowledge in type 2 Diabetic patients in Southern Punjab, Pakistan. Trop J Pharm Res. 2013;12:851–6.
Google Scholar
Doucette WR, Witry MJ, Farris KB, Mcdonough RP. Community pharmacist–provided extended Diabetes Care. Ann Pharmacother. 2009;43:882–9.
Article
Google Scholar
Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a Pharmaceutical Care Model on Diabetes Management. Ann Pharmacother. 1996;30:238–43.
Article
CAS
Google Scholar
Kraemer DF, Kradjan WA, Bianco TM, Low JA. A randomized study to assess the impact of Pharmacist Counseling of Employer-Based Health Plan beneficiaries with diabetes: the EMPOWER Study. J Pharm Pract. 2012;25:169–79.
Article
Google Scholar
Mourão AOM, Ferreira WR, Martins MAP, Reis AMM, Carrillo MRG, Guimarães AG, et al. Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial. Int J Clin Pharm. 2013;35:79–86.
Article
Google Scholar
Kirwin JL, Cunningham RJ, Sequist TD. Pharmacist recommendations to improve the quality of Diabetes Care: a Randomized Controlled Trial. JMCP. 2010;16:104–13.
Article
Google Scholar
Javaid Z, Imtiaz U, Khalid I, Saeed H, Khan RQ, Islam M, et al. A randomized control trial of primary care-based management of type 2 diabetes by a pharmacist in Pakistan. BMC Health Serv Res. 2019;19:409.
Article
Google Scholar
Ayadurai S, Sunderland VB, Tee LBG, Md Said SN, Hattingh HL. Structured tool to improve clinical outcomes of type 2 diabetes mellitus patients: a randomized controlled trial. J Diabetes. 2018;10:965–76.
Article
CAS
Google Scholar
Taveira TH, Friedmann PD, Cohen LB, Dooley AG, Khatana SAM, Pirraglia PA, et al. Pharmacist-led Group Medical Appointment Model in Type 2 diabetes. Diabetes Educ. 2010;36:109–17.
Article
Google Scholar
Wu W-C, Taveira TH, Jeffery S, Jiang L, Tokuda L, Musial J, et al. Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: a multi-center randomized controlled trial. PLoS ONE. 2018;13:e0195898.
Article
Google Scholar
Withidpanyawong U, Lerkiatbundit S, Saengcharoen W. Family-based intervention by pharmacists for type 2 diabetes: a randomised controlled trial. Patient Educ Couns. 2019;102:85–92.
Article
Google Scholar
Sarayani A, Mashayekhi M, Nosrati M, Jahangard-Rafsanjani Z, Javadi M, Saadat N, et al. Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice. Int J Clin Pharm. 2018;40:345–53.
Article
Google Scholar
Xin C, Xia Z, Jiang C, Lin M, Li G. Effect of pharmaceutical care on medication adherence of patients newly prescribed insulin therapy: a randomized controlled study. PPA. 2015;102:797.
Article
Google Scholar
Chen J-H, Ou H-T, Lin T-C, Lai EC-C, Yang Kao Y-H. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial. Int J Clin Pharm. 2016;38:88–95.
Article
CAS
Google Scholar
Scott DM, Boyd ST, Stephan M, Augustine SC, Reardon TP. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health-System Pharm. 2006;63:2116–22.
Article
Google Scholar
Clifford RM, Davis WA, Batty KT, Davis TME. Effect of a Pharmaceutical Care Program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28:771–6.
Article
Google Scholar
Plaster CP, Melo DT, Boldt V, et al. Reduction of cardiovascular risk in patients with metabolic syndrome in a community health center after a pharmaceutical care program of pharmacotherapy follow-up. Braz J Pharm Sci. 2012;48:435–46.
Article
Google Scholar
Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433–40.
Article
Google Scholar
Chan C-W, Siu S-C, Wong CKW, Lee VWY. A Pharmacist Care Program: positive impact on Cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther. 2012;17:57–64.
Article
Google Scholar
Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive Case Management of High-risk patients with type 2 diabetes Mellitus by a clinical pharmacist: a Randomized Controlled Trial. Am J Manag Care. 2005;11:8.
Google Scholar
Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med. 2005;118:276–84.
Article
Google Scholar
Erku D, Belachew S, Tegegn H, Ayele A. The impact of Pharmacist-LED medication Therapy Management on Medication Adherence in patients with type 2 diabetes Mellitus: a randomized controlled study. Value in Health. 2017;20:A402.
Article
Google Scholar
Ojieabu W, Bello S, Arute J. Evaluation of pharmacists’ educational and counselling impact on patients’ clinical outcomes in a diabetic setting. J Diabetol. 2017;8:7.
Article
Google Scholar
Shao H, Chen G, Zhu C, Chen Y, Liu Y, He Y, et al. Effect of pharmaceutical care on clinical outcomes of outpatients with type 2 diabetes mellitus. PPA. 2017;11:897–903.
Article
Google Scholar
Jameson JP, Baty PJ. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Am J Manag Care. 2010;16:250–5.
Google Scholar
Odegard PS, Christensen DB. MAP study: RCT of a medication adherence program for patients with type 2 diabetes. J Am Pharmacists Association. 2012;52:753–62.
Article
Google Scholar
Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T. Randomized Controlled Trial of Clinical Pharmacy Management of patients with type 2 diabetes in an Outpatient Diabetes Clinic in Jordan. JMCP. 2012;18:516–26.
Article
Google Scholar
Wishah RA, Al-Khawaldeh OA, Albsoul AM. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: randomized controlled trial. Diabetes Metab Syndr. 2015;9:271–6.
Article
Google Scholar
Chung WW, Chua SS, Lai PS, Chan SP. Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes. Patient Prefer Adherence. 2014;8:1185–94.
Google Scholar
Abuloha S, Alabbadi I, Albsoul-Younes A, Younes N, Zayed A. The role of clinical pharmacist in initiation and/or Dose Adjustment of insulin therapy in Diabetic Patients in Outpatient Clinic in Jordan. Jordan J Pharm Sci. 2016;9:18.
Article
Google Scholar
Jahangard-Rafsanjani Z, Sarayani A, Nosrati M, Saadat N, Rashidian A, Hadjibabaie M, et al. Effect of a community pharmacist–delivered diabetes support program for patients receiving Specialty Medical Care: a Randomized Controlled Trial. Diabetes Educ. 2015;41:127–35.
Article
Google Scholar
Aguiar PM, Silva CHP, Chiann C, Dórea EL, Lyra DP, Storpirtis S. Pharmacist–physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial. J Eval Clin Pract. 2018;24:22–30.
Article
Google Scholar
Sriram S, Chack LE, Ramasamy R, Ghasemi A, Ravi TK, Sabzghabaee AM. Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus. J Res Med Sci. 2011;16:412–8.
Google Scholar
Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci. 2011;16:43–9.
Google Scholar
Omran D, Guirguis LM, Simpson SH. Systematic review of Pharmacist Interventions to improve adherence to oral antidiabetic medications in people with type 2 diabetes. Can J Diabetes. 2012;36:292–9.
Article
Google Scholar
Pousinho S, Morgado M, Falcão A, Alves G. Pharmacist interventions in the management of type 2 diabetes Mellitus: a systematic review of Randomized controlled trials. JMCP. 2016;22:493–515.
Article
Google Scholar
Ramanath K, Balaji D, Nagakishore C, Kumar SM, Bhanuprakash M. A study on impact of clinical pharmacist interventions on medication adherence and quality of life in rural hypertensive patients. J Young Pharm. 2012;4:95–100.
Article
Google Scholar
Renuga E, Ramakrishnan SR, Rani N, Palani T, Kannan G. Impact of continuous patient counselling on knowledge, attitude, and practices and medication adherence of diabetic patients attending outpatient pharmacy services. Asian J Pharm Clin Res. 2016;9:345–50.
Google Scholar
Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26:1408–12.
Article
Google Scholar
Lyons I, Barber N, Raynor DK, Wei L. The Medicines advice service evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence. BMJ Qual Saf. 2016;25:759–69.
Article
Google Scholar
Fornos JA, Andrés NF, Andrés JC, Guerra MM, Egea B. A Pharmacotherapy Follow-Up program in patients with Type-2 diabetes in Community Pharmacies in Spain. Pharm World Sci. 2006;28:65–72.
Article
Google Scholar
Malathy R, Narmadha MP, Alvin Jose M, Ramesh S, Dinesh Babu N. Effect of a diabetes Counseling Programme on Knowledge, attitude and practice among Diabetic Patients in Erode District of South India. J Young Pharmacists. 2011;3:65–72.
Article
CAS
Google Scholar
Lauffenburger JC, Lewey J, Jan S, Makanji S, Ferro CA, Krumme AA, et al. Effectiveness of targeted insulin-adherence interventions for Glycemic Control using Predictive Analytics among patients with type 2 diabetes: a Randomized Clinical Trial. JAMA Netw Open. 2019;2:e190657.
Article
Google Scholar
Michiels Y, Bugnon O, Chicoye A, Dejager S, Moisan C, Allaert FA, et al. Impact of a community pharmacist-delivered information program on the follow-up of type-2 diabetic patients: a cluster randomized controlled study. Adv Ther. 2019;36:1291–303.
Article
CAS
Google Scholar
Ghosh S, Rajvanshi AK, Kishun S. Assessment the influence of patient counseling on uqality of life in type-II diabetes mellitus patients. Int J Pharma Bio Sci. 2010;1:1–6.
Google Scholar
Nagavi B, Adepu R, Rasheed A. Effect of patient counseling on quality of life in type-2 diabetes mellitus patients in two selected south indian community pharmacies: a study. Indian J Pharm Sci. 2007;69:519.
Article
Google Scholar
Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus. Br J Clin Pharmacol. 2009;67:547–57.
Article
CAS
Google Scholar
Chow EP, Hassali MA, Saleem F, Aljadhey H. Effects of pharmacist-led patient education on diabetes-related knowledge and medication adherence: a home-based study. Health Educ J. 2016;75:421–33.
Article
Google Scholar
Sarkadi A, Rosenqvist U. Experience-based group education in type 2 diabetes. Patient Educ Couns. 2004;53:291–8.
Article
Google Scholar
Venkatesan R, Manjula Devi A, Parasuraman S, Sriram S. Role of community pharmacists in improving knowledge and glycemic control of type 2 diabetes. Perspect Clin Res. 2012;3:26.
Article
CAS
Google Scholar
Cohen LB, Taveira TH, Khatana SAM, Dooley AG, Pirraglia PA, Wu W-C. Pharmacist-led Shared Medical appointments for multiple Cardiovascular Risk reduction in patients with type 2 diabetes. Diabetes Educ. 2011;37:801–12.
Article
Google Scholar
Castejón AM, Calderón JL, Perez A, Millar C, McLaughlin-Middlekauff J, Sangasubana N, et al. A community-based pilot study of a diabetes pharmacist intervention in Latinos: Impact on Weight and Hemoglobin A1c. J Health Care Poor Underserved. 2014;24:48–60.
Article
Google Scholar
Cani C, Lopes L, Queiroz M, Nery M. Improvement in medication adherence and self-management of diabetes with a clinical pharmacy program: a randomized controlled trial in patients with type 2 diabetes undergoing insulin therapy at a teaching hospital. Clinics. 2015;70:102–6.
Article
Google Scholar
Korcegez EI, Sancar M, Demirkan K. Effect of a pharmacist-led program on improving outcomes in patients with type 2 diabetes Mellitus from Northern Cyprus: a Randomized Controlled Trial. JMCP. 2017;23:573–82.
Article
Google Scholar
Ali M, Schifano F, Robinson P, Phillips G, Doherty L, Melnick P, et al. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study: community pharmacy diabetes monitoring and education programme. Diabet Med. 2012;29:e326–33.
Article
CAS
Google Scholar
Ruiz-Ramos J, Hernández MH, Juanes-Borrego AM, Milà R, Mangues-Bafalluy MA, Mestres C. The impact of Pharmaceutical Care in Multidisciplinary Teams on Health Outcomes: systematic review and Meta-analysis. J Am Med Dir Assoc. 2021;22:2518–26.
Article
Google Scholar
Howarth E, Bower PJ, Kontopantelis E, Soiland-Reyes C, Meacock R, Whittaker W, et al. ‘Going the distance’: an independent cohort study of engagement and dropout among the first 100 000 referrals into a large-scale diabetes prevention program. BMJ Open Diabetes Research and Care. 2020;8:e001835.
Article
Google Scholar
Cao DX, Tran RJC, Yamzon J, Stewart TL, Hernandez EA. Effectiveness of telepharmacy diabetes services: a systematic review and meta-analysis. Am J Health Syst Pharm. 2022;79:860–72.
Article
Google Scholar
Behavioural Interventions for Type 2 Diabetes. Ont Health Technol Assess Ser. 2009;9:1–45.
Google Scholar
Sapkota S, Brien J, Greenfield J, Aslani P. A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes–impact on adherence. PLoS ONE. 2015;10:e0118296.
Article
Google Scholar
Geurts MME, Talsma J, Brouwers JRBJ, de Gier JJ. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol. 2012;74:16–33.
Article
Google Scholar
Jokanovic N, Tan ECK, van den Bosch D, Kirkpatrick CM, Dooley MJ, Bell JS. Clinical medication review in Australia: a systematic review. Res Social Administrative Pharm. 2016;12:384–418.
Article
Google Scholar
Ahumada-Canale A, Quirland C, Martinez-Mardones FJ, Plaza-Plaza JC, Benrimoj S, Garcia-Cardenas V. Economic evaluations of pharmacist-led medication review in outpatients with hypertension, type 2 diabetes mellitus, and dyslipidaemia: a systematic review. Eur J Health Econ. 2019;20:1103–16.
Article
Google Scholar